The Food and Drug Administration (FDA) levied a $16 million fine against the American Red Cross for violating federal laws and regulations to ensure that blood products—red blood cells, plasma and platelets—are collected and manufactured safely, according to an FDA statement. However, the FDA points out that the noncompliance did not contaminate blood supplies. The American Red Cross is one of a few organizations responsible for supplying blood in the United States.

To read the FDA statement, click here.